Monaldi Hospital Rhythm Registry
Study Details
Study Description
Brief Summary
The study is a prospective registry. Consecutive patients with indications of implant / replacement or upgrade of pacemaker (PM), implantable cardioverter defibrillator (ICD), Implanted loop recorder (ILR) will be enrolled.
The primary objective of the study is to describe the clinical events during a long-term follow-up of non-selected population of patients implanted with an PM, ICD or ILR.
Condition or Disease | Intervention/Treatment | Phase |
---|---|---|
|
Study Design
Arms and Interventions
Arm | Intervention/Treatment |
---|---|
Patients with PM All patients underwent PM implantation |
Device: Device implantation
Implantation of single chamber, dual chambers or triple chambers PM/ICD
|
Patients with ICD All patients undeerwent ICD implantation |
Device: Device implantation
Implantation of single chamber, dual chambers or triple chambers PM/ICD
|
Patients with ILR All patients underwent ILR implantation |
Device: Device implantation
Implantation of single chamber, dual chambers or triple chambers PM/ICD
|
Outcome Measures
Primary Outcome Measures
- CIEDs Infection [through study completion, an average of 1 year]
The number of patecipants with infections following implantation of cardiac implantable electronic devices
- Appropriate ICD Therapies Antitachycardia pacing therapy or shock delivered by ICD for device detected ventricular arrhythmia [through study completion, an average of 1 year]
The number of partecipants with a least one episode of antitachycardia pacing therapy or shock delivered by ICD for device detected ventricular arrhythmias.
- Inappropriate ICD Therapies [through study completion, an average of 1 year]
The number of partecipants with at least one episode of antitachycardia pacing therapy or shock delivered by ICD for device detected sopraventricular arrhythmias.
Eligibility Criteria
Criteria
Inclusion Criteria:
-
All consecutive patients underwent PM/ICD/ILR implantation
-
Patient is willing and able to sign an authorization to use and disclose health information or an Informed Consent
-
Patient must be able to attend all required follow-up visits at the study center for at least 12 months
Exclusion Criteria:
-
No informed consent
-
Patient is participating in another clinical study that may have an impact on the study endpoint
Exclusion Criteria:
- No informed consent
Contacts and Locations
Locations
Site | City | State | Country | Postal Code | |
---|---|---|---|---|---|
1 | Vincenzo Russo | Naples | Napoli | Italy | 80136 |
Sponsors and Collaborators
- University of Campania "Luigi Vanvitelli"
Investigators
- Study Chair: Vincenzo Russo, MD PhD, University of Campania "Luigi Vanvitelli"
Study Documents (Full-Text)
None provided.More Information
Publications
None provided.- 22052021